Leonard Weinstock, MD - Inflammatory Bowel Disease II (2017 Conference) (LDN, low dose naltrexone)

Inflammatory bowel disease is a condition that we see as gastroenterologists on a daily basis. I'm Dr. Weinstock. I'd like to review inflammatory bowel disease, what the traditional approaches are, and some of the newer changes that we've seen with low dose naltrexone. Here are my disclosures.

Laurie Marzell, ND - LDN Case Studies (2017 Conference) (LDN, low dose naltrexone)

Paul Anderson, NMD - Case Studies (2017 Conference) (LDN, low dose naltrexone)

The first case is an oncology patient, a 47 year old female with colorectal cancer.  This lady presented herself while halfway through standard cancer treatment.  Dr Anderson added many adjunct therapies as well as Low Dose Naltrexone and the patients tumour markers reduced for the first time.

Yusuf Saleeby, MD - 20th Nov 2019 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.